Ebola

breaking news

IUIS-Immunopaedia-Frontiers webinar: In-depth characterisation of immune cells in Ebola virus.

Anita McElroy describes the cellular immune landscape that occurs following Ebola virus infection and will correlate these findings with key features of Ebola virus disease.

ChelekaJune 17, 2021

breaking news

Investigating Ebola immunity using single cell technologies

In a recent Cell article, Kotliar et al., utilise RNA-sequencing and mass cytometry to immune profile 21 rhesus monkeys before or during lethal Ebola virus challenge in vivo. This study…

ChelekaNovember 27, 2020

breaking news

Can profiling CD8 T cell responses from Ebola Survivors improve vaccine design?

31st July 2018 The role of CD8 T cells in protective vaccine induced responses against ebola virus is not clearly defined.

ChelekaJuly 31, 2018

Ebola virus budding from Monkey Cell line

breaking news

Functional antibody immunity 40 years post Ebolavirus exposure

15th December, 2017 Ebola virus diseases is caused by Ebolavirus spp, of which the Ebolavirus Zaire (EBOV-Zaire) is the most virulent and responsible for numerous Ebola outbreaks....

ChelekaDecember 15, 2017

breaking news

Insight into immune activation caused by Ebola virus

10th November, 2017One of the hallmarks of Ebola virus (EBOV) infection is a heightened immune response characterized by a "cytokine storm". Researchers investigated the cause...

Thandeka MoyoNovember 10, 2017

breaking news

Cross-reactive antibodies for Ebola vaccine

With the recent Ebola cases identified in the Democratic Republic of Congo, the need for a protective vaccine to prevent and control future outbreaks is once again highlighted. Researchers from...

Thandeka MoyoMay 21, 2017

breaking news

Ebola vaccine confirmed to be highly effective

23rd December, 2016Scientists from Canada’s National Microbiology laboratory have reported the successful results of the rVSV-ZEBOV vaccine trail conducted in Guinea.

Thandeka MoyoDecember 23, 2016

breaking news

Antibodies from Ebola survivor have potent anti-viral activity

16th November, 2016 Antibodies are the correlate of protection in most of the available, effective anti-viral vaccines. Therefore, it is important to understand the role...

Thandeka MoyoNovember 16, 2016

breaking news

Intact Ovine Immunoglobulin (EBOTAb) to Treat Ebola Virus Infection?

Researchers have now developed EBOTAb, a pool of intact ovine immunoglobulin G, which has been shown to neutralize Ebola virus (EBOV) in vitro. The primary target was the highly glycosylated…

Clive GrayMarch 21, 2016

breaking news

Fruit Bats and Flu

In the past, influenza A virus has been found in fruit bats from Guatemala, Central America. A recent publication in PloS Pathogens, has found similar viruses in bat species…

Bonamy HoltakOctober 31, 2014

IUIS-Immunopaedia-Frontiers webinar: In-depth characterisation of immune cells in Ebola virus.

Investigating Ebola immunity using single cell technologies

Can profiling CD8 T cell responses from Ebola Survivors improve vaccine design?

Functional antibody immunity 40 years post Ebolavirus exposure

Insight into immune activation caused by Ebola virus

Cross-reactive antibodies for Ebola vaccine

Ebola vaccine confirmed to be highly effective

Antibodies from Ebola survivor have potent anti-viral activity

Intact Ovine Immunoglobulin (EBOTAb) to Treat Ebola Virus Infection?

Fruit Bats and Flu

Advancing Global Online Immunology Education for 20 years

Join our Newsletter

Advancing Global Immunology Education